Neogen Chemicals' Q3 FY 2025-26 Quarterly Results

Result Summary

• Neogen Chemicals Ltd reported a 5.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 9.7%.
• Its expenses for the quarter were up by 5.3% QoQ and 15.6% YoY.
• The net profit increased 9.5% QoQ and decreased 63.1% YoY.
• The earnings per share (EPS) of Neogen Chemicals Ltd stood at 1.4 during Q3 FY 2025-26.

Financial Statments for Q3 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Neogen Chemicals Ltd is a prominent player in the chemical industry, primarily engaged in the manufacturing of specialty chemicals. The company focuses on producing organic and inorganic chemicals that cater to the pharmaceutical, agrochemical, and engineering industries. Neogen Chemicals has established a robust portfolio of products, including bromine and lithium compounds, which are critical in various industrial applications. The company has been known for its strong emphasis on research and development, aiming to innovate and expand its product range. Recent developments include efforts to increase production capacity and enhance operational efficiency.

Revenue

In Q3FY26, Neogen Chemicals Ltd reported a total income of ₹222.11 crores, reflecting a quarter-over-quarter (QoQ) increase of 5.5% compared to ₹210.55 crores in Q2FY26. Year-over-year (YoY), the total income grew by 9.7% from ₹202.49 crores in Q3FY25. This upward trend in revenue suggests a consistent demand for the company's products across its key markets. The company's strategic initiatives and product offerings may have contributed to this growth in revenue, maintaining a positive trajectory from the previous quarters.

Profitability

The company's profitability metrics for Q3FY26 reveal a profit before tax (PBT) of ₹5.65 crores, which marks an 11.7% increase from the ₹5.06 crores reported in Q2FY26. However, when compared to Q3FY25, the PBT has seen a significant decline of 62.8% from ₹15.17 crores. The tax expense for Q3FY26 was ₹2.07 crores, which is a 16.3% increase QoQ and a 60.5% decline YoY. The profit after tax (PAT) for the quarter stood at ₹3.69 crores, up by 9.5% QoQ but down by 63.1% YoY. Earnings per share (EPS) followed a similar pattern, increasing by 9.4% QoQ to ₹1.40, while experiencing a YoY decline of 63.2% from ₹3.80. These figures highlight a substantial YoY decrease in profitability despite a QoQ improvement.

Operating Metrics

The total expenses for Neogen Chemicals in Q3FY26 amounted to ₹216.46 crores, which is 5.3% higher than the ₹205.49 crores recorded in Q2FY26 and 15.6% higher than the ₹187.32 crores in Q3FY25. This increase in expenses both QoQ and YoY suggests sustained operational costs, which have impacted the company's profit margins. The financial data does not provide specific details on the company's financial ratios, such as P/E ratio or debt-to-equity ratio, which would typically be used to assess financial health. However, the trends in income and expenses provide insights into the company's operational dynamics during the quarter.